PBAC Public Summary Documents – December 2021
Page last updated: 14 April 2022
Public Summary Documents relating to the December 2021 PBAC meeting.
- Elexacaftor/tezacaftor/ivacaftor: Pack containing 56 tablets of elexacaftor 100 mg with tezacaftor 50 mg and ivacaftor 75 mg and 28 tablets of ivacaftor 150 mg; Trikafta®
- Lorlatinib: Tablet 25 mg, Tablet 100 mg; Lorviqua®
- Lumacaftor + ivacaftor: Tablet containing lumacaftor 100 mg with ivacaftor 125 mg; Orkambi®
